Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China

scientific article

Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2015PLoSO..1035269L
P356DOI10.1371/JOURNAL.PONE.0135269
P3181OpenCitations bibliographic resource ID4645296
P932PMC publication ID4529152
P698PubMed publication ID26252888
P5875ResearchGate publication ID281610051

P2093author name stringYun Li
Jian Liu
Feng Xue
Ya Li
Bo Zheng
Sainan Zhu
P2860cites workAntimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.Q54349458
Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin.Q54590227
Characterization of spontaneous fosfomycin (phosphonomycin)-resistant cells of Escherichia coli B in vitroQ54621230
Functional Consequence of Covalent Reaction of Phosphoenolpyruvate with UDP-N-acetylglucosamine 1-Carboxyvinyltransferase (MurA)Q27677546
Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coliQ30451453
Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferaseQ33202551
Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymesQ33962732
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.Q34096605
An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS ProjectQ34166158
The mechanism of action of fosfomycin (phosphonomycin)Q34214482
Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infectionsQ34421301
In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012).Q35087433
Biological costs and mechanisms of fosfomycin resistance in Escherichia coliQ35685710
Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in ChinaQ35867426
Genome sequence of Escherichia coli J53, a reference strain for genetic studiesQ36086565
Isolation and Characterization of a Phosphonomycin-Resistant Mutant of Escherichia coli K-12Q36776831
Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K-12Q40145885
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coliQ43195414
Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal originQ44513436
Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?Q46634720
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectPeople's Republic of ChinaQ148
Escherichia coliQ25419
antibiotic resistanceQ380775
antimicrobial resistanceQ63391344
P304page(s)e0135269
P577publication date2015-01-01
P1433published inPLOS OneQ564954
P1476titleAntimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China
P478volume10

Reverse relations

cites work (P2860)
Q36675246Fosfomycin
Q90189782Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics
Q39071416Fosfomycin: Mechanism and Resistance
Q48380261Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.
Q40645840Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.
Q92354615In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections
Q40333130Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates
Q50950504Molecular insights into fosfomycin resistance in Escherichia coli.
Q37023175Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae
Q33597689Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae
Q28596830Surveillance of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Dairy Cattle Farms in the Nile Delta, Egypt
Q40550094The detection of fosfomycin resistance genes in Enterobacteriaceae from pets and their owners

Search more.